Analysis of clinicopathological factors and CHRNB2 expression showed no correlation with tumor markers, tumor depth, and lymph node metastasis, and high CHRNB2 was an independent poor prognostic factor along with wall depth T4 in multivariate analysis. The gene discussed is CHRNB2; the disease is neoplasm.